RAB1A and colorectal carcinoma: Our findings indicated that patients with higher Rab1A and FoxM1 expression had shorter survival time compared to those with lower expression of Rab1A and FoxM1 in CRC (P < 0.001, P < 0.001) (Fig. 4B,C).